Roivant Sciences Ltd expected to post a loss of 30 cents a share - Earnings Preview

Roivant Sciences

28/05/2024 13:55

* Roivant Sciences Ltd  ROIV.OQ   ROIV.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 30 for
the period ending March 31 2024
    * The London United Kingdom-based   company is expected to
report
a 17.3% increase in revenue to $32.101 million from $27.38
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Roivant Sciences Ltd is
for a
loss of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Roivant
Sciences
Ltd is $16.00​, above​ its last closing price of $10.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.32       -0.32      -0.30     Beat    6.3
 Sep. 30 2023  -0.31       -0.31      -0.40     Missed  -29.6
 Jun. 30 2023  -0.30       -0.30      -0.38     Missed  -27.7​
 Mar. 31 2023  -0.35       -0.36      -0.20     Beat    44.6
 ​​Dec.        -0.39       -0.39      -0.49     Missed  -26.8
 31 2022                                                
 Sep. 30 2022  -0.42       -0.42      -0.42     Met     -1.1​
 Jun. 30 2022  -0.33       -0.32      -0.48     Missed  -48.4
 Mar. 31 2022  -0.34       -0.32      -0.27     Beat    16.3
 This summary was machine generated May 28 at 12:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)